Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.

International journal of clinical and experimental pathology - 1 Jan 2015

Liu Qiuyu, Kan Yunzhen, Zhao Yuewu, He Hui, Kong Lingfei

Abstract excerpt

Epithelioid inflammatory myofibroblastic sarcoma is extremely rare and belongs to a variant of inflammatory myofibrobalstic tumor with aggressive clinical course. We describe a case of a 22 years old man presented with an abdominal huge tumor. Microscopically, the neoplasm cells were rounded and epithelioid in shape. Abundant interstitial edema and less myxoid stroma were also present together with an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Abdominal Neoplasms
Share to Anaplastic Lymphoma Kinase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Crizotinib

Share to Myofibroblasts

Share to Pyrazoles

Share to Sarcoma

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 26823889
PMCID: PMC4713675

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.PMID 26823889Read ↗

Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcomaSemantic proximity Read ↗

Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.Semantic proximity Read ↗

Crizotinib combined with bronchoscopic interventional treatment in ALK-positive Inflammatory myofibroblastic tumor of left main stem bronchus: a case reportSemantic proximity Read ↗

A Case Report of RRBP1-ALK Fusion Gene-Positive Epithelioid Inflammatory Myofibroblastic Sarcoma With Collagenous StromaSemantic proximity Read ↗

ALK-Negative Lung Inflammatory Myofibroblastic Tumor in a Young Adult: a Case Report and Literature Review of Molecular AlterationsSemantic proximity Read ↗

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.Semantic proximity Read ↗

[Uterine inflammatory myofibroblastic tumor: a clinicopathological and molecular genetic analysis of eight cases].Semantic proximity Read ↗

Inflammatory Myofibroblastic Tumor in the Inguinal canal: A Rare Case ReportSemantic proximity Read ↗

Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases.Semantic proximity Read ↗

Inflammatory Myofibroblastic Tumour of an Unusual Presentation in the Uterine Cervix: A Case ReportSemantic proximity Read ↗

A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature reviewSemantic proximity Read ↗

Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.